Factors | Value | Percent |
---|---|---|
Age | 50.5 ± 12.4 |  |
Gender (male/female) | 67/7 | 90.5/9.5 |
BCLC Stage | ||
 A | 2 | 2.7 |
 B | 34 | 45.9 |
 C | 38 | 51.4 |
Types of cirrhosis | ||
 Normal | 17 | 23.3 |
 Micronodular | 4 | 5.4 |
 Macronodular | 34 | 45.9 |
 Mixed | 19 | 25.7 |
TNM stage | ||
 1 | 32 | 43.2 |
 2 | 36 | 48.7 |
 3 | 6 | 8.1 |
 Neoadjuvant Therapy | 0 | 0 |
 Hepatectomy | 74 | 100 |
Laboratory values | ||
 White blood cell (× 109/L) | 5.48 ± 1.99 |  |
 Platelet (× 109/L) | 146 ± 73 |  |
 Total bilirubin (umol/L) | 14.6 ± 5.5 |  |
 Direct bilirubin (umol/L) | 5.6 ± 2.7 |  |
 Albumin (g/L) | 42.6 ± 4.1 |  |
 ALT (U/L) | 56.1 ± 40.5 |  |
 AST (U/L) | 42.7 ± 21.4 |  |
 Glucose (mmol/L) | 5.0 ± 1.0 |  |
 CEA (ng/ml) | 4.2 ± 7.9 |  |
 CA19-9 (U/ml) | 14.9 ± 8.5 |  |
 AFP (ng/ml) | 324.7 ± 425.3 |  |